- Home
- Automated
- List of product information
- FLAGYSTATIN VAGINAL OVULE [SIN03798P]
FLAGYSTATIN VAGINAL OVULE [SIN03798P]
Active ingredients: FLAGYSTATIN VAGINAL OVULE
Last updated 26 October 2025
On this page
Product Info
FLAGYSTATIN VAGINAL OVULE
[SIN03798P]
Product information
Active Ingredient and Strength | METRONIDAZOLE - 500 MG |
Dosage Form | SUPPOSITORY |
Manufacturer and Country | PT KALVENTIS SINERGI FARMA - INDONESIA REP OF |
Registration Number | SIN03798P |
Licence Holder | SANOFI-AVENTIS SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | G01AA01 |
INDICATIONS
Mixed vaginal infection due to Trichomonas vaginalis and C. albicans.
DOSAGE
One vaginal ovule daily, inserted deep into vagina, before retiring for 10 consecutive days.
In order to facilitate disintegration, moisten the vaginal tablet under water for a second or two just before introduction in the vagina.
If after 10 days of treatment a cure has not been achieved, a second 10 day course of treatment should be given. If Trichomonas vaginalis has not been completely eliminated, oral metronidazole 250 mg should be administered twice daily for 10 days.
The applicator should not be used after the 7th month of pregnancy.
CONTRAINDICATIONS
Hypersensitivity to FLAGYSTATIN (metronidazole and nystatin), or to imidazoles, or any of its constituents, including any non-medicinal ingredient, or component of the container. For a complete listing, see DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.
Combined treatment with oral metronidazole should be avoided in cases of active neurological disorders or a history of blood dyscrasia, hypothyroidism or hypoadrenalism unless, in the opinion of the physician, the benefits outweigh the possible hazard to the patient.